Search

Author/Creator Smits, L

2. P490 Drug survival and immunogenicity after switching from Remicade® to biosimilar CT-P13 in inflammatory bowel disease patients: Two-year follow-up of a prospective observational cohort study. (16th January 2018)

Authors:
Smits, L; Derikx, L; van Esch, A; Drenth, J; Boshuizen, R; de Jong, D; Hoentjen, F
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S353
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P526 A prediction model for successful increase of adalimumab dose intervals: analysis of the pragmatic open-label randomised controlled non-inferiority LADI trial. (30th January 2023)

Authors:
Van Linschoten, R; Jansen, F; Pauwels, R; Smits, L; Atsma, F; Kievit, W; de Jong, D; de Vries, A; Boekema, P; West, R; Bodelier, A; Gisbertz, I; Wolfhagen, F; Romkens, T; Lutgens, M; van Bodegraven, A; Oldenburg, B; Pierik, M; Russel, M; de Boer, N
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i655
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗